Maxcyte (MXCT) Change in Acquisitions & Divestments (2020 - 2026)

Maxcyte has reported Change in Acquisitions & Divestments over the past 6 years, most recently at $38.2 million for Q4 2025.

  • Quarterly Change in Acquisitions & Divestments rose 23.1% to $38.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $155.8 million through Dec 2025, down 2.31% year-over-year, with the annual reading at $155.8 million for FY2025, 2.31% down from the prior year.
  • Change in Acquisitions & Divestments was $38.2 million for Q4 2025 at Maxcyte, down from $40.0 million in the prior quarter.
  • Over five years, Change in Acquisitions & Divestments peaked at $200.8 million in Q1 2022 and troughed at $6.0 million in Q3 2021.
  • The 5-year median for Change in Acquisitions & Divestments is $43.0 million (2024), against an average of $52.2 million.
  • Year-over-year, Change in Acquisitions & Divestments surged 1154.97% in 2022 and then tumbled 61.29% in 2024.
  • A 5-year view of Change in Acquisitions & Divestments shows it stood at $55.5 million in 2021, then fell by 5.41% to $52.5 million in 2022, then grew by 26.19% to $66.2 million in 2023, then tumbled by 53.21% to $31.0 million in 2024, then increased by 23.1% to $38.2 million in 2025.
  • Per Business Quant, the three most recent readings for MXCT's Change in Acquisitions & Divestments are $38.2 million (Q4 2025), $40.0 million (Q3 2025), and $31.0 million (Q2 2025).